Results 51 to 60 of about 5,954,376 (381)

Correction of menopausal disorders: new possibilities of menopausal hormone therapy

open access: yesМедицинский совет, 2022
Determining the role of menopausal hormone therapy in the era of covid infection is an urgent task. The reasons for the lower rate of severe outcomes in women against the background of covid infection compared to men are currently being discussed.
L. Yu. Karakhalis
doaj   +1 more source

An increase in N-Ras expression is associated with development of hormone refractory prostate cancer in a subset of patients [PDF]

open access: yes, 2008
Protein expression of H, K and N-Ras was assessed in hormone sensitive and hormone refractory prostate tumour pairs from 61 patients by immunohistochemistry. Expression of H-Ras and K- Ras was not associated with any known clinical parameters.
Bartlett, J.M.S.   +5 more
core   +3 more sources

Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles.

open access: yesPLoS Medicine, 2011
BackgroundEven after the Women's Health Initiative (WHI) found that the risks of menopausal hormone therapy (hormone therapy) outweighed benefit for asymptomatic women, about half of gynecologists in the United States continued to believe that hormones ...
Adriane Fugh-Berman   +4 more
doaj   +1 more source

Long-term hormone therapy for perimenopausal and postmenopausal women.

open access: yesCochrane Database of Systematic Reviews, 2017
BACKGROUND: Hormone therapy (HT) is widely provided for control of menopausal symptoms and has been used for the management and prevention of cardiovascular disease, osteoporosis and dementia in older women.
J. Marjoribanks   +4 more
semanticscholar   +1 more source

Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study

open access: yesBritish medical journal, 2019
Objectives To compare the use of hormone therapy between Finnish postmenopausal women with and without a diagnosis for Alzheimer’s disease. Design Nationwide case-control study. Setting Finnish national population and drug register, between 1999 and 2013.
H. Savolainen-Peltonen   +6 more
semanticscholar   +1 more source

Individual approach to choosing an appropriate regimen of adjuvant hormone therapy in patients with early-stage breast cancer

open access: yesОпухоли женской репродуктивной системы, 2018
Adjuvant hormone therapy is considered the gold standard of therapy for hormone receptor-positive operable breast cancer. The approach to adjuvant hormone therapy in premenopausal patients has changed significantly in recent years. This change was caused
E. M. Slonimskaya   +4 more
doaj   +1 more source

Health considerations for transgender women and remaining unknowns : a narrative review [PDF]

open access: yes, 2019
Transgender (trans) women (TW) were assigned male at birth but have a female gender identity or gender expression. The literature on management and health outcomes of TW has grown recently with more publication of research.
Defreyne, Justine   +6 more
core   +1 more source

International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate : A meta-analysis of 1446 patients [PDF]

open access: yes, 2007
OBJECTIVE: To review pooled phase II data to identify features of different regimens of intermittent hormone therapy (IHT), developed to reduce the morbidity of treating metastatic prostate cancer, and which carries a theoretical advantage of delaying ...
Cuzick, Jack   +6 more
core   +1 more source

Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

open access: yesMolecular Oncology, EarlyView.
Circulating tumor DNA (ctDNA) offers a possibility for different applications in early and late stage breast cancer management. In early breast cancer tumor informed approaches are increasingly used for detecting molecular residual disease (MRD) and early recurrence. In advanced stage, ctDNA provides a possibility for monitoring disease progression and
Eva Valentina Klocker   +14 more
wiley   +1 more source

Variable response to growth hormone therapy in growth hormone deficient patients and role of insulin like growth factor one in monitoring response to therapy

open access: yesAdvanced Medical Journal, 2023
Background and objectives: To find out the response to growth hormone therapy among growth hormone deficiency patients with different causes and to find out the role of insulin-like growth factor one in monitoring response.
Kawes Omer Zangana   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy